June 5, 2024
Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
Bethlehem, PA – May 14, 2024 – Saladax Biomedical, Inc. (Saladax) is pleased to announce…
September 19, 2018
Saladax Biomedical Welcomes New Guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil Therapy
Bethlehem, PA – September 19, 2018 – Saladax Biomedical Inc., a diagnostics company providing kits…
October 14, 2017
Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel
Saladax Biomedical, Inc., recently presented a study on the value of adjusting paclitaxel doses. The…
October 19, 2016
Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated Neuropathy
Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic tests, today announced…
July 23, 2014
Personalized Chemotherapy Tests Cleared for Use in China
Exposure Optimization Tests Fosun Diagnostics, a division of Fosun Pharmaceuticals, and Saladax Biomedical, Inc. today…
